Top 10 Companies in the United States Bone Morphogenetic Proteins 7 Market (2026): Market Leaders Driving Innovation

The United States Bone Morphogenetic Proteins 7 market size was valued at USD 98.6 million in 2025 and is projected to reach USD 134.7 million by 2034, at a CAGR of 5.3% during the forecast period 2025-2034.

Bone Morphogenetic Protein 7 (BMP-7) is a growth factor that stimulates bone and cartilage formation, used in orthopedic and dental procedures to enhance bone healing and regeneration.
The U.S. Bone Morphogenetic Proteins 7 market is experiencing moderate growth, driven by an aging population and increasing orthopedic surgeries. In 2023, total consumption reached 25,000 units, with spinal fusion procedures accounting for 50% of demand. The dental implant segment is growing at 7% annually. The market saw a 12% increase in demand for BMP-7 in non‑union fracture treatments in 2023. Combination therapies using BMP-7 with other growth factors are growing at 9% annually, driven by improved efficacy. The trend towards minimally invasive surgeries led to a 15% rise in adoption of injectable BMP-7 formulations. Off‑label use in cosmetic and reconstructive surgeries saw a 10% surge, despite regulatory challenges. The market is witnessing increased focus on developing sustained‑release formulations, with a 20% growth in R&D investments for improved delivery systems.

Download the detailed research report:
United States Bone Morphogenetic Proteins 7 Market – View in Detailed Research Report

This report contains market size and forecasts of Bone Morphogenetic Proteins 7 in United States, including the following market information:

United States Bone Morphogenetic Proteins 7 Market Revenue, 2019-2025, 2025-2034 (USD millions)
United States Bone Morphogenetic Proteins 7 Market Sales, 2019-2025, 2025-2034
United States Top five Bone Morphogenetic Proteins 7 companies in 2023 (%)

Report Includes

This report presents an overview of United States market for Bone Morphogenetic Proteins 7, sales, revenue and price. Analyses of the United States market trends, with historic market revenue/sales data for 2019-2023, estimates for 2025, and projections of CAGR through 2034.

This report focuses on the Bone Morphogenetic Proteins 7 sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2025. Identification of the major stakeholders in the United States Bone Morphogenetic Proteins 7 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues.

This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

Segment by Type

Sponge
Gel

Segment by Applications

Spinal Fusion
Trauma Surgery
Oral Maxillofacial Surgery
Reconstructive

Key Companies covered in this report:

Medtronic
Stryker Corporation
Zimmer Biomet
DePuy Synthes (Johnson & Johnson)
Thermo Fisher Scientific
BioHorizons
Orthofix Medical Inc.
NuVasive, Inc.
Wright Medical Group N.V.
Smith & Nephew

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bone Morphogenetic Proteins 7 revenues in United States market, 2019-2025 (Estimated), ($ millions)
Key companies Bone Morphogenetic Proteins 7 revenues share in United States market, 2023 (%)
Key companies Bone Morphogenetic Proteins 7 sales in United States market, 2019-2025 (Estimated)
Key companies Bone Morphogenetic Proteins 7 sales share in United States market, 2023 (%)

Key Indicators Analysed

Market Players & Competitor Analysis: Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2019-2034 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
United States Market Analysis: United States market status and outlook 2019-2034. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology.
Porter’s Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In‑depth analysis of the Bone Morphogenetic Proteins 7 Market
Overview of the regional outlook of the Bone Morphogenetic Proteins 7 Market

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub‑segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in‑depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6‑month post‑sales analyst support

We offer additional regional and global reports that are similar:

Global Bone Morphogenetic Proteins 7 Market
United States Bone Morphogenetic Proteins 7 Market
Japan Bone Morphogenetic Proteins 7 Market
Germany Bone Morphogenetic Proteins 7 Market
South Korea Bone Morphogenetic Proteins 7 Market
Indonesia Bone Morphogenetic Proteins 7 Market
Brazil Bone Morphogenetic Proteins 7 Market

Customization of the Report: In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

🔟 1. Medtronic

Headquarters: Minneapolis, Minnesota, USA
Key Offering: BMP-7 in sponge and gel formats for spinal fusion and trauma applications

Medtronic has positioned itself as a pioneer in regenerative orthopedics by integrating BMP-7 into its flagship bone graft products. The company’s focus on minimally invasive delivery systems aligns with the rising preference for less invasive procedures.

Sustainability & Growth Initiatives:

Investment in sustained‑release BMP-7 formulations to extend therapeutic windows
Partnerships with academic centers to validate long‑term efficacy
Expansion of distribution networks into emerging orthopedic markets

9️⃣ 2. Stryker Corporation

Headquarters: Kalamazoo, Michigan, USA
Key Offering: BMP-7 enhanced bone grafts for spinal fusion and oral maxillofacial surgery

Stryker’s portfolio emphasizes high‑density bone graft carriers that deliver BMP-7 efficiently during complex reconstructions.

Strategic Moves:

Acquisition of a small‑scale bio‑fabrication firm to boost production capacity
Collaboration with dental implant manufacturers to broaden application reach
R&D focus on bio‑compatible carrier materials

8️⃣ 3. Zimmer Biomet

Headquarters: Warsaw, Indiana, USA
Key Offering: BMP-7 incorporated into orthopedic implants for trauma and reconstructive procedures

The company leverages its extensive implant platform to embed BMP-7 directly into fixation devices, reducing the need for separate graft materials.

Innovation Highlights:

Development of hybrid implants that combine mechanical support with growth factor delivery
Strategic alliances with research institutions for pre‑clinical testing
Focus on regulatory pathways to expedite market entry

7️⃣ 4. DePuy Synthes (Johnson & Johnson)

Headquarters: Memphis, Tennessee, USA
Key Offering: BMP-7 enriched bone graft substitutes for spinal fusion and trauma surgery

DePuy Synthes emphasizes product consistency and scalability, ensuring that BMP‑7 solutions meet the stringent demands of high‑volume orthopedic centers.

Key Initiatives:

Expansion of GMP facilities to support increased production
Partnerships with implant manufacturers for integrated solutions
Focus on post‑market surveillance to track long‑term outcomes

6️⃣ 5. Thermo Fisher Scientific

Headquarters: Waltham, Massachusetts, USA
Key Offering: BMP-7 reagents for research and clinical applications, including diagnostic kits for bone healing biomarkers

Thermo Fisher’s strength lies in its research‑grade supply chain, supporting both academic and clinical investigations into BMP-7 efficacy.

R&D Focus:

Development of rapid diagnostic tools to monitor BMP-7 activity in vivo
Collaborations with pharmaceutical companies for combination therapy development
Investment in high‑throughput screening platforms for novel delivery carriers

5️⃣ 6. BioHorizons

Headquarters: San Diego, California, USA
Key Offering: BMP-7 based bone grafts for spinal fusion and trauma applications

BioHorizons has carved a niche by offering BMP‑7 products that are tailored for specific surgical contexts, ensuring optimal dosing and delivery.

Strategic Directions:

Expansion of product line to include BMP-7 loaded hydrogel carriers
Partnerships with orthopedic surgeons to refine application protocols
Focus on cost‑effective manufacturing processes to enhance market penetration

4️⃣ 7. Orthofix Medical Inc.

Headquarters: Irvine, California, USA
Key Offering: BMP-7 enhanced bone grafts for spinal fusion and reconstructive procedures

Orthofix prioritizes integration of BMP-7 into its existing spinal implant portfolio, providing a seamless solution for surgeons.

Key Initiatives:

Development of carrier systems that reduce surgical time
Collaborations with health systems to gather real‑world evidence
Investment in digital platforms to support surgeon training

3️⃣ 8. NuVasive, Inc.

Headquarters: San Diego, California, USA
Key Offering: BMP-7 incorporated into minimally invasive spine devices

NuVasive leverages its expertise in minimally invasive spine solutions to embed BMP-7 into its device offerings, aligning with the 15% rise in injectable formulations.

Growth Strategy:

Expansion of the minimally invasive product line to include BMP-7 carriers
Partnerships with key opinion leaders to drive adoption
Focus on regulatory approvals for off‑label indications

2️⃣ 9. Wright Medical Group N.V.

Headquarters: Amsterdam, Netherlands (U.S. operations in New York, USA)
Key Offering: BMP-7 based bone grafts for trauma and reconstructive surgery

Wright Medical’s global footprint supports the distribution of BMP‑7 products across North America, ensuring supply chain resilience.

Key Focus Areas:

Expansion of distribution networks within the U.S.
Investment in supply chain digitization
Collaboration with surgical device manufacturers for integrated solutions

1️⃣ 10. Smith & Nephew

Headquarters: London, United Kingdom (U.S. presence in San Diego, USA)
Key Offering: BMP-7 enhanced bone grafts for spinal fusion and trauma applications

Smith & Nephew combines its robust implant platform with BMP‑7 to deliver a comprehensive solution for complex reconstructions.

Strategic Priorities:

Development of next‑generation carriers that support sustained release
Partnerships with academic centers to validate clinical outcomes
Focus on cost‑effective production to support volume growth

Download FREE Sample Report:
United States Bone Morphogenetic Proteins 7 Market – View in Detailed Research Report

Get Full Report:
United States Bone Morphogenetic Proteins 7 Market – View in Detailed Research Report

🌍 Outlook: The Future of United States Bone Morphogenetic Proteins 7 Market

The trajectory of the BMP‑7 market in the U.S. will be shaped by the convergence of demographic shifts, surgical innovation, and regulatory evolution. The aging population will sustain demand, while advances in minimally invasive techniques will keep the market buoyant. The focus on sustained‑release delivery systems and combination therapies is likely to drive incremental value, provided that manufacturers can navigate the complex regulatory landscape and maintain cost competitiveness.

📈 Future Trends Shaping the Market:

Expansion of combination therapies that pair BMP‑7 with other growth factors to enhance healing outcomes
Growth of off‑label applications in cosmetic and reconstructive surgery, driven by patient demand for improved aesthetic results
Increased investment in sustained‑release delivery platforms to reduce dosing frequency and improve patient compliance
Digital tracking of BMP‑7 usage and outcomes to support evidence‑based practice and regulatory compliance
Strategic collaborations between biomaterial developers and implant manufacturers to create integrated solutions

Author
Recent Posts

Rohit k